Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05809362 · ClinicalTrials.gov registry record
WHOOP Abnormal Rhythm Notification
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 653
- Enrollment target
NCT05809362 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 653 participants.
The verdict
NCT05809362 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 653 participants
- Enrollment target
Study Summary
The purpose of this protocol is to assess the sensitivity and specificity of a photoplethysmography (PPG)-based algorithm for the detection of atrial fibrillation as compared to a gold-standard assessment (wearable ECG patch) among a population of individuals with known atrial fibrillation and without known atrial fibrillation over a 7-day study period.
Interventions
- DEVICE WHOOP 4.0 Strap
- DEVICE BioTel ePatch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 653 participants |
| Start Date | 2023-04-10 |
| Est. Completion | 2024-01-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05809362
The ClinicalTrials.gov registry entry for NCT05809362 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 653 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which WHOOP 4.0 Strap is the first listed.
NCT05809362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05809362 about?
NCT05809362 is a clinical study titled "WHOOP Abnormal Rhythm Notification". The purpose of this protocol is to assess the sensitivity and specificity of a photoplethysmography (PPG)-based algorithm for the detection of atrial fibrillation as compared to a gold-standard assessment (wearable ECG patch) among a population of individuals with known atrial fibrillation and witho...
What is the current status of trial NCT05809362?
This trial is currently completed. The enrollment target is 653 participants. The study started on 2023-04-10. Estimated completion is 2024-01-25.
What interventions are being tested in trial NCT05809362?
The interventions under investigation include: WHOOP 4.0 Strap (DEVICE), BioTel ePatch (DEVICE).
Who is sponsoring clinical trial NCT05809362?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.